发布时间:
2026
-
09
-
10
Recently, the CBI 2026 Biomedical Innovation Expo concluded in Suzhou, with an exhibition area of over 36,000 square meters and more than 20,000 participants gathered on site to jointly create a new industry ecosystem. The conference featured multiple parallel forums. At the ADC New Drug Discovery and Front-End Technology Innovation Forum, Dr. Dang Qun, President of Real Biotechnology, shared the company's latest achievements in overcoming ADC drug resistance with its novel non-camptothecin TOPO1 inhibitor platform.ImagePrecision therapeutic approaches represented by next-generation ADC dr...
浏览次数:2